Charles River Laboratories
CRL
Charles River Laboratories (CRL) Fails to deliver data
Key failure to deliver metrics for Charles River Laboratories :
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $1.08 M
- Last 3 months FTD volume: $5.5 M
- Last year FTD volume: $20.68 M
Failures to deliver for Charles River Laboratories (CRL) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Charles River Laboratories (CRL) - since 2013
Volume in USD (price x number of shares), data since 2013Charles River Laboratories (CRL) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $5.5 M | -82.63% |
| 2023 | $31.66 M | 62.47% |
| 2022 | $19.48 M | -87.64% |
| 2021 | $0.15 B | 8824.4% |
| 2020 | $1.76 M | -63.26% |
| 2019 | $4.8 M | -68.26% |
| 2018 | $15.14 M | 134.01% |
| 2017 | $6.47 M | -63.94% |
| 2016 | $17.95 M | 138.39% |
| 2015 | $7.52 M | 97.99% |
| 2014 | $3.8 M | -81.01% |
| 2013 | $20.02 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $0.18 B | $0.40 B | 🇺🇸 USA |
 SCYNEXIS SCYX | $0 M | $1.32 M | 🇺🇸 USA |
 Repligen
RGEN | $8.5 M | $0.10 B | 🇺🇸 USA |